QuidelOrtho Corporation (QDEL)
USD 42.46
(-1.32%)
USD 42.46
(-1.32%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 545.6 Million USD | -36.28% |
| 2022 | 1.09 Billion USD | 20.58% |
| 2021 | 955.44 Million USD | -13.95% |
| 2020 | 1.09 Billion USD | 919.34% |
| 2019 | 143.75 Million USD | -5.21% |
| 2018 | 133.93 Million USD | 322.62% |
| 2017 | 40.31 Million USD | 462.32% |
| 2016 | 18.77 Million USD | -60.03% |
| 2015 | 11.59 Million USD | 264.82% |
| 2014 | 19.15 Million USD | -77.63% |
| 2013 | 29.73 Million USD | -10.04% |
| 2012 | 15.79 Million USD | -25.04% |
| 2011 | 31.37 Million USD | 447.18% |
| 2010 | -2.74 Million USD | -110.69% |
| 2009 | 59.28 Million USD | 63.25% |
| 2008 | 39.12 Million USD | 18.08% |
| 2007 | 31.11 Million USD | 31.51% |
| 2006 | 22.94 Million USD | 30.78% |
| 2005 | 176 Thousand USD | 132.42% |
| 2004 | 7.36 Million USD | -65.97% |
| 2003 | 21.18 Million USD | 183.88% |
| 2002 | 11.7 Million USD | -26.86% |
| 2001 | 10.43 Million USD | 145.35% |
| 2000 | 5.21 Million USD | 0.0% |
| 1998 | 600 Thousand USD | -1750.0% |
| 1997 | 900 Thousand USD | -125.0% |
| 1996 | 3.8 Million USD | -55.56% |
| 1995 | 2.5 Million USD | 166.67% |
| 1994 | -2 Million USD | 3.57% |
| 1993 | -1.4 Million USD | -380.0% |
| 1992 | 1 Million USD | 25.0% |
| 1991 | 1.9 Million USD | 155.88% |
| 1990 | -3.4 Million USD | -666.67% |
| 1989 | 600 Thousand USD | 127.27% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 120.8 Million USD | -1333.91% |
| 2024 Q2 | 85.8 Million USD | 99.23% |
| 2023 Q2 | 47.7 Million USD | -73.08% |
| 2023 Q1 | 177.2 Million USD | 13.52% |
| 2023 FY | - USD | -36.28% |
| 2023 Q3 | 100.1 Million USD | 109.85% |
| 2023 Q4 | 40.1 Million USD | -59.94% |
| 2022 FY | - USD | 20.58% |
| 2022 Q1 | 640.47 Million USD | 66.56% |
| 2022 Q2 | 178.4 Million USD | -72.15% |
| 2022 Q3 | 137.9 Million USD | -22.7% |
| 2022 Q4 | 156.1 Million USD | 13.2% |
| 2021 Q4 | 384.53 Million USD | 36.44% |
| 2021 FY | - USD | -13.95% |
| 2021 Q2 | 24.33 Million USD | -89.76% |
| 2021 Q3 | 281.84 Million USD | 1058.22% |
| 2021 Q1 | 237.62 Million USD | -61.52% |
| 2020 Q1 | 53.54 Million USD | 42.35% |
| 2020 Q4 | 617.59 Million USD | 100.29% |
| 2020 FY | - USD | 919.34% |
| 2020 Q3 | 308.34 Million USD | 264.76% |
| 2020 Q2 | 84.53 Million USD | 57.89% |
| 2019 FY | - USD | -5.21% |
| 2019 Q2 | 7.65 Million USD | -77.47% |
| 2019 Q1 | 33.97 Million USD | 10.27% |
| 2019 Q4 | 37.61 Million USD | 49.63% |
| 2019 Q3 | 25.13 Million USD | 228.43% |
| 2018 FY | - USD | 322.62% |
| 2018 Q1 | 54.56 Million USD | 308.05% |
| 2018 Q3 | 30.11 Million USD | 464.13% |
| 2018 Q2 | 5.33 Million USD | -90.21% |
| 2018 Q4 | 30.81 Million USD | 2.3% |
| 2017 Q1 | 21.52 Million USD | 93.63% |
| 2017 FY | - USD | 462.32% |
| 2017 Q4 | 13.37 Million USD | 193.42% |
| 2017 Q3 | 4.55 Million USD | 172.82% |
| 2017 Q2 | -6.25 Million USD | -129.08% |
| 2016 Q3 | 4.39 Million USD | 165.36% |
| 2016 FY | - USD | -60.03% |
| 2016 Q4 | 11.11 Million USD | 152.71% |
| 2016 Q1 | -1.24 Million USD | -125.43% |
| 2016 Q2 | -6.72 Million USD | -442.22% |
| 2015 Q2 | -7.6 Million USD | -169.85% |
| 2015 FY | - USD | 264.82% |
| 2015 Q3 | 3.43 Million USD | 145.1% |
| 2015 Q1 | 10.89 Million USD | -27.98% |
| 2015 Q4 | 4.88 Million USD | 42.23% |
| 2014 Q4 | 15.12 Million USD | 447.11% |
| 2014 Q2 | -7.77 Million USD | -70800.0% |
| 2014 Q1 | 11 Thousand USD | -99.7% |
| 2014 FY | - USD | -77.63% |
| 2014 Q3 | -4.35 Million USD | 43.99% |
| 2013 Q1 | 18.95 Million USD | 19.31% |
| 2013 Q3 | -3.67 Million USD | 28.05% |
| 2013 FY | - USD | -10.04% |
| 2013 Q4 | 3.64 Million USD | 199.29% |
| 2013 Q2 | -5.1 Million USD | -126.91% |
| 2012 Q3 | 514 Thousand USD | 118.42% |
| 2012 Q2 | -2.79 Million USD | -226.52% |
| 2012 Q1 | 2.2 Million USD | -72.21% |
| 2012 FY | - USD | -25.04% |
| 2012 Q4 | 15.89 Million USD | 2991.44% |
| 2011 Q4 | 7.93 Million USD | 1247.54% |
| 2011 Q1 | 19.77 Million USD | 545.01% |
| 2011 FY | - USD | 447.18% |
| 2011 Q2 | -1.66 Million USD | -108.39% |
| 2011 Q3 | 589 Thousand USD | 135.48% |
| 2010 Q1 | -87 Thousand USD | -100.25% |
| 2010 Q4 | 3.06 Million USD | 321.21% |
| 2010 Q3 | -1.38 Million USD | 72.35% |
| 2010 Q2 | -5.01 Million USD | -5660.92% |
| 2010 FY | - USD | -110.69% |
| 2009 Q4 | 34.19 Million USD | 38.71% |
| 2009 Q2 | 3.61 Million USD | 285.62% |
| 2009 Q1 | -1.94 Million USD | -116.74% |
| 2009 Q3 | 24.65 Million USD | 582.15% |
| 2009 FY | - USD | 63.25% |
| 2008 Q1 | 15.64 Million USD | 14.63% |
| 2008 FY | - USD | 18.08% |
| 2008 Q4 | 11.63 Million USD | 18.91% |
| 2008 Q3 | 9.78 Million USD | 891.08% |
| 2008 Q2 | 987 Thousand USD | -93.69% |
| 2007 FY | - USD | 31.51% |
| 2007 Q2 | -761 Thousand USD | -107.32% |
| 2007 Q4 | 13.64 Million USD | 121.2% |
| 2007 Q3 | 6.16 Million USD | 910.64% |
| 2007 Q1 | 10.4 Million USD | -21.39% |
| 2006 FY | - USD | 30.78% |
| 2006 Q4 | 13.23 Million USD | 236.07% |
| 2006 Q3 | 3.93 Million USD | 302.83% |
| 2006 Q2 | -1.94 Million USD | -127.07% |
| 2006 Q1 | 7.17 Million USD | -32.07% |
| 2005 Q1 | 2.66 Million USD | -77.66% |
| 2005 Q4 | 10.55 Million USD | 542.87% |
| 2005 Q3 | 1.64 Million USD | 195.08% |
| 2005 Q2 | -1.72 Million USD | -164.78% |
| 2005 FY | - USD | 132.42% |
| 2004 Q1 | 749 Thousand USD | -93.14% |
| 2004 FY | - USD | -65.97% |
| 2004 Q2 | -4.25 Million USD | -668.49% |
| 2004 Q3 | -5.7 Million USD | -34.01% |
| 2004 Q4 | 11.93 Million USD | 309.13% |
| 2003 Q3 | 1.19 Million USD | 105.23% |
| 2003 Q4 | 9.76 Million USD | 406.54% |
| 2003 Q2 | 875 Thousand USD | -64.68% |
| 2003 Q1 | 3.49 Million USD | 67.0% |
| 2003 FY | - USD | 183.88% |
| 2002 FY | - USD | -26.86% |
| 2002 Q4 | 2.26 Million USD | 197.06% |
| 2002 Q1 | 3.34 Million USD | 11.86% |
| 2002 Q2 | 1.17 Million USD | -75.36% |
| 2002 Q3 | -1.48 Million USD | -366.86% |
| 2001 Q3 | 1.72 Million USD | 255.82% |
| 2001 Q4 | 2.91 Million USD | 109.4% |
| 2001 FY | - USD | 145.35% |
| 2001 Q1 | 2.69 Million USD | -53.73% |
| 2001 Q2 | -102 Thousand USD | -126.78% |
| 2000 Q3 | -4.88 Million USD | -8301.61% |
| 2000 Q4 | 4.44 Million USD | 221.42% |
| 2000 Q1 | 3.47 Million USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q2 | 62 Thousand USD | -98.17% |
| 1999 Q2 | 700 Thousand USD | 96.0% |
| 1999 Q1 | -2.8 Million USD | -494.74% |
| 1999 Q3 | -700 Thousand USD | 133.33% |
| 1998 FY | - USD | -1750.0% |
| 1998 Q1 | -200 Thousand USD | 225.0% |
| 1998 Q2 | 100 Thousand USD | -92.31% |
| 1998 Q4 | 2 Million USD | 1800.0% |
| 1998 Q3 | 200 Thousand USD | 0.0% |
| 1997 Q2 | -700 Thousand USD | -275.0% |
| 1997 Q4 | 1.5 Million USD | -63.64% |
| 1997 FY | - USD | -125.0% |
| 1997 Q1 | 1.6 Million USD | -20.0% |
| 1997 Q3 | 1.2 Million USD | 178.57% |
| 1996 FY | - USD | -55.56% |
| 1996 Q4 | 1.7 Million USD | 0.0% |
| 1996 Q3 | 1 Million USD | 300.0% |
| 1996 Q2 | 200 Thousand USD | -66.67% |
| 1996 Q1 | 400 Thousand USD | -127.27% |
| 1995 Q1 | -2 Million USD | -336.36% |
| 1995 Q2 | 500 Thousand USD | 119.23% |
| 1995 Q3 | 600 Thousand USD | 20.0% |
| 1995 Q4 | 1.1 Million USD | 83.33% |
| 1995 FY | - USD | 166.67% |
| 1994 FY | - USD | 3.57% |
| 1994 Q4 | 1.1 Million USD | 257.14% |
| 1994 Q3 | -300 Thousand USD | 36.36% |
| 1994 Q2 | -1.1 Million USD | 57.69% |
| 1994 Q1 | -1.4 Million USD | -766.67% |
| 1993 Q1 | -100 Thousand USD | -125.0% |
| 1993 Q4 | -200 Thousand USD | -400.0% |
| 1993 FY | - USD | -380.0% |
| 1993 Q3 | 100 Thousand USD | 150.0% |
| 1993 Q2 | -200 Thousand USD | -100.0% |
| 1992 Q4 | 600 Thousand USD | -33.33% |
| 1992 Q1 | 700 Thousand USD | 66.67% |
| 1992 Q2 | -100 Thousand USD | -160.0% |
| 1992 Q3 | 600 Thousand USD | 300.0% |
| 1992 FY | - USD | 25.0% |
| 1991 Q4 | 500 Thousand USD | -50.0% |
| 1991 Q1 | -26 Million USD | -471.43% |
| 1991 FY | - USD | 120.0% |
| 1991 Q2 | 500 Thousand USD | 101.92% |
| 1991 Q3 | 700 Thousand USD | 20.0% |
| 1990 Q2 | 6.9 Million USD | 207.81% |
| 1990 Q1 | -6.4 Million USD | -366.67% |
| 1990 Q4 | 7 Million USD | 1.45% |
| 1990 FY | - USD | -385.71% |
| 1990 Q3 | 6.9 Million USD | 0.0% |
| 1989 FY | - USD | 158.33% |
| 1989 Q1 | -9.5 Million USD | -513.04% |
| 1989 Q2 | 1.8 Million USD | 118.95% |
| 1989 Q4 | 2.4 Million USD | 4.35% |
| 1989 Q3 | 2.3 Million USD | 27.78% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 1295.652% |
| AngioDynamics, Inc. | -14.29 Million USD | 3917.52% |
| AtriCure, Inc. | -8.1 Million USD | 6828.327% |
| Avinger, Inc. | -16.34 Million USD | 3437.82% |
| Azenta, Inc. | 55.15 Million USD | -889.284% |
| BioLife Solutions, Inc. | -45.23 Million USD | 1306.066% |
| The Cooper Companies, Inc. | 882.8 Million USD | 38.197% |
| Daxor Corporation | 329.74 Thousand USD | -165363.699% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 4233.96% |
| Femasys Inc. | -13.16 Million USD | 4242.934% |
| GlucoTrack, Inc. | -7.09 Million USD | 7794.26% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -5647.393% |
| Hologic, Inc. | 1.29 Billion USD | 57.908% |
| ICU Medical, Inc. | 307.69 Million USD | -77.319% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 77.211% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 5904.509% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | -1013.697% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 8397.928% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 8397.928% |
| Masimo Corporation | 236.7 Million USD | -130.503% |
| Microbot Medical Inc. | -10.63 Million USD | 5230.713% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -3359.613% |
| Merit Medical Systems, Inc. | 231.44 Million USD | -135.739% |
| Nephros, Inc. | -1.37 Million USD | 39664.902% |
| NovoCure Limited | -175.86 Million USD | 410.238% |
| NEXGEL, Inc. | -2.73 Million USD | 20085.348% |
| NEXGEL, Inc. | -2.73 Million USD | 20085.348% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 730.781% |
| OraSure Technologies, Inc. | 76.15 Million USD | -616.405% |
| Pro-Dex, Inc. | 8.33 Million USD | -6447.462% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 1387.795% |
| Predictive Oncology Inc. | -13.18 Million USD | 4238.974% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 21820.169% |
| Repligen Corporation | 124.29 Million USD | -338.966% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 188825.583% |
| STAAR Surgical Company | 33.22 Million USD | -1542.335% |
| Sharps Technology, Inc. | -8.98 Million USD | 6175.459% |
| Utah Medical Products, Inc. | 24.8 Million USD | -2099.557% |
| DENTSPLY SIRONA Inc. | 232 Million USD | -135.172% |
| Jin Medical International Ltd. | 3.44 Million USD | -15747.175% |